PROCTER & GAMBLE COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171.09 USD | +1.27% |
|
+1.31% | +16.75% |
| Oct. 11 | Health of US consumer in focus as earnings season heats up | RE |
| Oct. 10 | DA Davidson Initiates Procter & Gamble at Neutral With $159 Price Target | MT |
Highlights: Procter & Gamble Company
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses: Procter & Gamble Company
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- With a 2025 P/E ratio at 24.77 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
Ratings Chart: Procter & Gamble Company
Source: Surperformance
ESG chart: Procter & Gamble Company
Source: Refinitiv
| Composite Fundamentals | Composite Valuation | Composite Momentum | Capi. ($) | ||
|---|---|---|---|---|---|
| 402B | |||||
| 156B | |||||
| 81.79B | |||||
| 77.68B | |||||
| 41.1B | |||||
| 34.47B | |||||
| 32.8B | |||||
| 20.99B | |||||
| 16B | |||||
| 12.03B | |||||
| Average | 87.48B | ||||
| Weighted average by Cap. |
Investor Rating
Trading Rating
ESG Refinitiv
C-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PG Stock
- Ratings Procter & Gamble Company